Agenus Inc (AGEN)

NASDAQ HEALTHCARE
$3.00 +1.35% RSI 40 Neutral Add Alert

Moving Averages

SMA 200
$3.76
Price below

Company Profile

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$141.17M
P/E Ratio
1.654
EPS
$2.05
Beta
1.605
Dividend Yield
0.00%
52-Week High
$7.34
52-Week Low
$2.71

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 48.0
VRTX
Vertex Pharmaceuticals Inc
RSI 64.0
CRSP
CRISPR Therapeutics AG
RSI 56.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 49.0
MRNA
Moderna Inc
RSI 64.0
VKTX
Viking Therapeutics Inc
RSI 60.0
SRPT
Sarepta Therapeutics Inc
RSI 54.0
EDIT
Editas Medicine Inc
RSI 48.0
IOVA
Iovance Biotherapeutics Inc
RSI 54.0
NVAX
Novavax Inc
RSI 48.0

Data last updated: June 13, 2026 at 3:27 AM EDT

Track AGEN for free

Get e-mail RSI alerts when Agenus Inc enters oversold or overbought territory. Free forever.

Add Alert